b'20052020 and BEYOND SHIFTING PARADIGMS: THE PRISM OF COLLABORATIONABBY ROSENBERG, MD, MS, MADirector, Palliative Care and Resilience Lab,Seattle Childrens Research InstituteDirector, Pediatrics, Cambia Palliative Care Center ofExcellence at the University of WashingtonAssociate Professor, Division of Hematology-Oncology;Associate Professor, Department of Pediatrics,University of Washington School of Medicine2016 Pilot and Exploratory Awardee:Promoting Resiliencein Stress Management (PRISM): A Novel SupportiveIntervention for Parents of Children with CancerDr. Abby Rosenberg is a celebrated medical innovator, dedicated to improving quality of life for people with serious illness and their families. Her work focuses on building interventions to improve resilience; simply said, she figures out how to help people feel more resilient when illness makes that a difficult state of mind to achieve. After developing PRISMa resilience intervention for teenagers with serious illness, developed with patients for patientsDr. Rosenberg expanded the reach of her program, adapting and transforming it to meet the needs of the parents of seriously ill teenagers. Today PRISM has expanded in highly original and unexpected ways. Within the palliative care community, people are refining its use for adult patients with congenital heart disease and for people of color who have experienced discrimination in the healthcare setting. In response to the pandemic, the intervention is being used to build resilience for frontline healthcare workers and for school-age kids suffering from the stress of social isolation. Dr. Rosenberg and her team are testing PRISM in the cystic fibrosis and chronic pain communities, and in her world of pediatric oncology, Dr. Rosenberg has continued to expand the application of PRISM with two big, multisite NIH trials. One is evaluating PRISMs impact and cost-effectiveness among youth receiving hematopoietic cell transplantation; the other is evaluating PRISMs impact on quality of life and advance care planning among youth with advanced cancer.Palliative care research is hard to fund, partly because our work goes against the traditional basic science paradigm; its about seeing the patients whole experience and recognizing that this person, who happens to be ill, is a human being with all the emotional, familial, medical, and spiritual needs that being human entails. So palliative care researchers spend lots of time convincing potential funders of the value of our work.The beauty of NPCRC is that it recognizes this value from the start. It provides a forum,a meeting place, and badly needed funding, all of which form the backbone of innovation.By bringing together our small, spread out community, experts can join forces to break boundaries and advance our shared cause. Through collaboration were improving ourscience by extraordinary leaps and bounds. Were shifting conventional perceptions,inspiring breakthrough ideas, and finding new and powerful ways of helping patients.15'